LCM
HALO icon

Legato Capital Management’s Halozyme HALO Stock Holding History

Legato Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$935K Buy
+14,460
New +$1.02M 0.09% 309
2024
Q4 		– Sell
-20,419
Closed -$1.17M – 590
2024
Q3 		$1.17M Buy
20,419
+5,806
+40% +$333K 0.14% 259
2024
Q2 		$765K Buy
+14,613
New +$641K 0.1% 327

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legato Capital Management's HALO Position: Q1 2026 in Review

Legato Capital Management opened a new position in Halozyme (HALO) in Q1 2026: 14,460 shares worth $935K. The stake represents 0.09% of the portfolio and ranks #309 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in HALO as recently as Q3 2024.

Legato Capital Management first reported a position in HALO in Q2 2024 and has held it in 3 quarters since. The position peaked at $1.17M in Q3 2024. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Legato Capital Management held 14,460 shares of Halozyme worth $935K as of Q1 2026.
  • Halozyme was a new Legato Capital Management position in Q1 2026.
  • Halozyme made up 0.09% of Legato Capital Management's portfolio in Q1 2026, its #309 holding.
  • Legato Capital Management first reported a position in Halozyme in Q2 2024 and has held it in 3 quarters since.
  • Legato Capital Management's Halozyme position peaked at $1.17M in Q3 2024.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.